VINC
Income statement / Annual
Last year (2023), Vincerx Pharma, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Vincerx Pharma, Inc.'s net income was -$40.16 M.
See Vincerx Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$915,000.00
|
$939,000.00
|
$340,000.00
|
$172,996.00
|
$172,996.00
|
Gross Profit |
-$915,000.00
|
-$939,000.00
|
-$340,000.00
|
-$172,996.00
|
-$172,996.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$28.06 M
|
$52.15 M
|
$40.08 M
|
$7.12 M
|
$0.00
|
General & Administrative Expenses |
$13.64 M
|
$18.95 M
|
$22.58 M
|
$3.60 M
|
$54,000.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$44,946.00
|
Selling, General & Administrative Expenses |
$13.64 M
|
$18.95 M
|
$22.58 M
|
$3.60 M
|
$45,000.00
|
Other Expenses |
$0.00
|
$1.24 M
|
-$8,000.00
|
-$8,000.00
|
$0.00
|
Operating Expenses |
$42.61 M
|
$71.11 M
|
$62.66 M
|
$10.71 M
|
$45,000.00
|
Cost And Expenses |
$42.61 M
|
$71.11 M
|
$62.66 M
|
$10.71 M
|
$45,000.00
|
Interest Income |
$1.25 M
|
$664,000.00
|
$0.00
|
$54,266.00
|
$54,266.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$8,000.00
|
$0.00
|
Depreciation & Amortization |
$52,000.00
|
$939,000.00
|
$340,000.00
|
$5.71 M
|
$54,000.00
|
EBITDA |
-$42.61 M |
-$68.67 M |
-$62.66 M |
-$10.71 M |
$9,000.00 |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$2.45 M
|
$8.21 M
|
$23.35 M
|
-$5.91 M
|
$0.00
|
Income Before Tax |
-$40.16 M
|
-$65.37 M
|
-$39.31 M
|
-$10.72 M
|
-$45,000.00
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
-$8.21 M
|
-$23.70 M
|
$8,000.00
|
-$54.00
|
Net Income |
-$40.16 M
|
-$57.16 M
|
-$15.61 M
|
-$10.73 M
|
-$45,000.00
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
EPS |
-1.89 |
-2.72 |
-0.91 |
-0.77 |
-0.0087 |
EPS Diluted |
-1.89 |
-2.72 |
-0.91 |
-0.77 |
-0.0087 |
Weighted Average Shares Out |
$21.30 M
|
$21.03 M
|
$17.18 M
|
$13.98 M
|
$5.20 M
|
Weighted Average Shares Out Diluted |
$21.30 M
|
$21.03 M
|
$17.18 M
|
$13.98 M
|
$5.20 M
|
Link |
|
|
|
|
|